Reslizumab

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Reslizumab and local guidelines before prescribing.

Biologic (anti-IL-5)

Mechanism

Anti-IL-5 monoclonal antibody (IV).

Uses

Severe eosinophilic asthma.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Anaphylaxis (rare), myalgia, raised CK.

Interactions

Few.

Contraindications and cautions

Active parasitic infection

Monitoring

Asthma control

Pregnancy and breastfeeding

Limited data

Renal and hepatic impairment

No adjustment

Overdose and reversal

Supportive

Special advice

Intravenous weight-based infusion.

More from the textbook: uses, cautions and other points
Where it is discussed in the book